R. Acquah

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Prevalence and Risk Factors of Hearing Loss among Pediatric Patients at a Tertiary Teaching Hospital in Accra

R. Acquah, 2015 .

Universal regimens or universal access to drug susceptibility testing for tuberculosis?

J. Furin, R. Acquah, 2019, The Lancet. Infectious diseases.

Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients

M. Loveday, J. Furin, J. Daniels, 2021, The Pediatric infectious disease journal.

Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB.

A. Skrahina, Z. Udwadia, U. Khan, 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.